Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global Forecast to 2024

ポイントオブケア診断の世界市場予測:グルコース、感染症(C型肝炎、インフルエンザ、呼吸器)、凝固

◆タイトル:Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global Forecast to 2024
◆商品コード:MD 2702
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年11月21日
◆ページ数:219
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥539,550見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥724,850見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥888,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は、ポイントオブケア診断の世界市場規模が2019年285億ドルから2024年467億ドルまで年平均10.4%成長すると予測しています。当調査レポートでは、ポイントオブケア診断の世界市場について調査・分析し、市場概要、製品別(グルコースモニタリング製品、心臓代謝モニタリング製品、感染症検査製品、凝固モニタリング製品、妊娠および妊娠検査製品、腫瘍/がんマーカー検査製品、尿検査製品、コレステロール検査製品、血液検査製品、薬物乱用検査製品、 便潜血検査製品、その他のPOC製品)分析、プラットフォーム別(ラテラルフローアッセイ、ディップスティック、マイクロフルイディクス、分子診断、免疫アッセイ)分析、購入方法別(処方ベース製品、OTC製品)分析、エンドユーザー別(専門診断センター、病院/クリティカルケアセンター、在宅ケア施設、研究所、その他のエンドユーザー)分析、地域別(北米、ヨーロッパ、アジア太平洋など)分析、競合環境、企業概要、付録などを含め次の構成でお届け致します。

・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・ポイントオブケア診断の世界市場:製品別(グルコースモニタリング製品、心臓代謝モニタリング製品、感染症検査製品、凝固モニタリング製品、妊娠および妊娠検査製品、腫瘍/がんマーカー検査製品、尿検査製品、コレステロール検査製品、血液検査製品、薬物乱用検査製品、 便潜血検査製品、その他のPOC製品)
・ポイントオブケア診断の世界市場:プラットフォーム別(ラテラルフローアッセイ、ディップスティック、マイクロフルイディクス、分子診断、免疫アッセイ)
・ポイントオブケア診断の世界市場:購入方法別(処方ベース製品、OTC製品)
・ポイントオブケア診断の世界市場:エンドユーザー別(専門診断センター、病院/クリティカルケアセンター、在宅ケア施設、研究所、その他のエンドユーザー)
・ポイントオブケア診断の世界市場:地域別(北米、ヨーロッパ、アジア太平洋など)
・競合環境
・企業概要
・付録

“The point-of-care diagnostics market is projected to grow at a CAGR of 10.4% from 2019 to 2024.”
The global point-of-care diagnostics market is projected to reach USD 46.7 billion by 2024 from USD 28.5 billion in 2019, at a CAGR of 10.4%. Factors such as the high prevalence of infectious diseases in developing countries, increasing incidence of target conditions, and increasing inclination toward home healthcare across the globe are driving the market for point-of-care diagnostics. However, product recalls, a lack of alignment with test results obtained from laboratories, stringent & time-consuming approval policies, and a reluctance to change existing diagnostic practices are expected to restrain market growth.

“The glucose monitoring products segment is expected to command the largest share of the POC diagnostics market in 2019.”
Based on product, the point-of-care diagnostics market is segmented into glucose monitoring, infectious disease testing, cardiometabolic monitoring, coagulation monitoring, hematology testing, urinalysis testing, cholesterol testing, drugs-of-abuse testing, tumor/cancer markers, pregnancy & fertility testing, fecal occult testing, and other POC products. The glucose monitoring products segment is expected to command the largest share of the market in 2019. The increasing number of POC glucose monitoring devices, coupled with the growing prevalence of diabetes, is expected to drive the growth of the POC diagnostics market for glucose monitoring products in the coming years.

“The microfluidics segment is expected to register the highest growth rate in the POC diagnostics market, by platform, during the forecast period.”
On the basis of platform, the point-of-care diagnostics market is segmented into lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays. The microfluidics segment is expected to register the highest growth rate during the forecast period. Technological advancements and increasing initiatives by market players for developing novel microfluidics-based POC products are propelling the growth of the microfluidics market.

“The Asia Pacific market is expected to register the highest CAGR during the forecast period.”
The point-of-care diagnostics market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is expected to register the highest growth rate during the forecast period, due to the growing initiatives by market players, increasing patient population base, and rising number of partnerships and joint ventures in this region.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
• By Designation: C-level: 26%, Director-level: 30%, and Others: 44%
• By Region: North America: 34%, Europe: 26%, APAC: 23%, and the RoW: 17%

Prominent players of the point-of-care diagnostics market are Abbott (US), Roche (Switzerland), Siemens (Germany), Danaher (US), Becton, Dickinson, and Company (US), Johnson & Johnson (US), Instrumentation Laboratory (US), PTS Diagnostics (US), Quidel (US), Chembio Diagnostic Systems (US), Sekisui Diagnostics (US), Nova Biomedical (US), EKF Diagnostics (UK), AccuBioTech (China), and Trinity Biotech (Ireland).

Research Coverage
This report studies the point-of-care diagnostics market based on product, platform, mode of purchase, end user, and region. The report also studies factors affecting market growth, analyzes opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends. The report forecasts the revenue of the market segments with respect to the five key regions and their respective countries.

Key Benefits of Buying the Report:
From an insights perspective, this research report has focused on various levels of analysis, such as market share analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the point-of-care diagnostics market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

【レポートの目次】

1 Introduction (Page No. – 19)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 22)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Market Size Estimation: Overall Market
2.2.3 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Research Limitations & Assumptions
2.4.1 Limitations
2.4.2 Assumptions
3 Executive Summary (Page No. – 32)
4 Premium Insights (Page No. – 36)
4.1 POC Diagnostics Market Overview
4.2 Geographic Analysis: POC Diagnostics Market
4.3 POC Diagnostics Market, By Product
4.4 POC Diagnostics Market, By Prescription Mode
4.5 Geographic Snapshot of the POC Diagnostics Market
5 Market Overview (Page No. – 40)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Prevalence of Infectious Diseases in Developing Countries
5.2.1.2 Increasing Incidence of Target Conditions
5.2.1.3 Growing Government Support
5.2.1.4 Shortage of Skilled Laboratory Technicians
5.2.1.5 Rising Number of Clia-Waived POC Tests
5.2.2 Restraints
5.2.2.1 Pricing Pressure Owing to Reimbursement Cuts and Budget Constraints
5.2.2.2 Stringent and Time-Consuming Regulatory Policies
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Healthcare Decentralization—Converting Lab Tests to POC Tests
5.2.3.3 Increasing Awareness Through Conferences and Events
5.2.3.4 POC Tests With Multiplexing Capabilities
5.2.4 Challenges
5.2.4.1 Lack of Alignment With Definitive Central Lab Methods
5.2.4.2 Inadequate Knowledge About the Use of POC Devices in Professional Settings
5.2.4.3 Reluctance to Change Existing Diagnostic Practices
5.2.4.4 High Cost of Devices
5.2.4.5 Product Recalls
5.2.5 Emerging Applications of Point-Of-Care Testing
5.2.5.1 Sepsis Biomarkers
5.2.5.2 Stroke Markers
5.2.5.3 Thyroid Testing
5.2.5.4 Dna Testing
5.2.5.5 Endocrine Testing
6 Point-Of-Care Diagnostics Market, By Product (Page No. – 52)
6.1 Introduction
6.2 Glucose Monitoring Products
6.2.1 Glucose Monitoring Products Account for the Largest Share of the POC Diagnostics Market
6.2.2 Strips
6.2.3 Meters
6.2.4 Lancets & Lancing Devices
6.3 Cardiometabolic Monitoring Products
6.3.1 Cardiac Marker Testing Products
6.3.1.1 Rising Government Initiatives for Cvd Research Will Contribute to Market Growth
6.3.2 Blood Gas/Electrolyte Testing Products
6.3.2.1 Technological Advancements in Blood Gas/Electrolytes Products Will Drive the Growth of This Market Segment
6.3.3 Hba1c Testing Products
6.3.3.1 Government Initiatives are Promoting the Regular Use of Hba1c Testing
6.4 Infectious Disease Testing Products
6.4.1 Influenza Testing Products
6.4.1.1 Rising Influenza Prevalence has Driven Demand for Market Products
6.4.2 Hiv Testing Products
6.4.2.1 Rising Prevalence of Hiv to Drive Market Growth
6.4.3 Hepatitis C Testing Products
6.4.3.1 Central and East Asia are Among the Highly Affected Regions With Hepatitis C
6.4.4 Sexually Transmitted Disease Testing Products
6.4.4.1 Privacy and Confidentiality Issues are the Key Factors Leading to the Adoption of POC Std Testing Products
6.4.5 Healthcare-Associated Infection Testing Products
6.4.5.1 Rising Prevalence of Hais is the Key Factor Driving Market Growth
6.4.6 Respiratory Infection Testing Products
6.4.6.1 POCt Products for the Diagnosis of Respiratory Infections Offer Lower Sensitivity as Compared to Other Tests
6.4.7 Tropical Disease Testing Products
6.4.7.1 Increasing Government Funding for the Use of POC in Tropical Disease Testing Will Support Market Growth
6.4.8 Other Infectious Disease Testing Products
6.5 Coagulation Monitoring Products
6.5.1 Pt/Inr Testing Products
6.5.1.1 Pt/Inr is One of the Most Commonly Used Coagulation Monitoring Methods
6.5.2 Act/Aptt Testing Products
6.5.2.1 Rising Number of Patients Undergoing Angioplasty and Dialysis Globally are Driving Demand for Market Products
6.6 Pregnancy & Fertility Testing Products
6.6.1 Pregnancy Testing Products
6.6.1.1 Pregnancy Testing Will Account for A Larger Market Share Owing to the Rising Inclination Toward Home Testing
6.6.2 Fertility Testing Products
6.6.2.1 Increasing Awareness of Fertility Testing to Drive Market Growth
6.7 Tumor/Cancer Marker Testing Products
6.7.1 Increasing Investments for Research Related to POC Cancer Testing are Driving Growth
6.8 Urinalysis Testing Products
6.8.1 Rising Prevalence of Urinary Tract Infections is Driving Market Growth
6.9 Cholesterol Testing Products
6.9.1 Rising Obesity Levels & Cardiovascular Disorder Incidence are the Key Factors Supporting Market Growth
6.1 Hematology Testing Products
6.10.1 Preference for Laboratory-Based Tests Among Users Will Impede Market Growth
6.11 Drugs-Of-Abuse Testing Products
6.11.1 Rising Consumption of Illicit Drugs has Boosted Demand for Testing
6.12 Fecal Occult Testing Products
6.12.1 Lack of Proper Training in the Use of Fecal Occult Testing Hampers Market Adoption
6.13 Other POC Products
7 Point-Of-Care Diagnostics Market, By Platform (Page No. – 78)
7.1 Introduction
7.2 Lateral Flow Assays
7.2.1 Technological Advancements and Increasing Adoption of Lfa are Supporting Market Growth
7.3 Dipsticks
7.3.1 Dipsticks Help in Routine Analysis of Several Medical Conditions
7.4 Microfluidics
7.4.1 Microfluidics is an Emerging Platform in POC Diagnostics
7.5 Molecular Diagnostics
7.5.1 Increasing Initiatives By Market Players for Developing POC Molecular Diagnostic Products to Drive Market Growth
7.6 Immunoassays
7.6.1 Rising Incidence of Cancer and Growing Awareness About Immunoassay Platforms to Support Market Growth
8 Point-Of-Care Diagnostics Market, By Mode of Purchase (Page No. – 83)
8.1 Introduction
8.2 Prescription-Based Products
8.2.1 Growing Prevalence of Lifestyle Diseases and Favorable Reimbursement Have Driven Market Growth
8.3 OTC Products
8.3.1 Rising Focus on Home Care is Expected to Boost Demand for OTC Testing in the Coming Years
9 Point-Of-Care Diagnostics Market, By End User (Page No. – 87)
9.1 Introduction
9.2 Professional Diagnostic Centers
9.2.1 Clinical Laboratories and Outpatient Healthcare & Ambulatory Care Settings
9.2.1.1 Rapid Result Generation and Availability of Immediate Patient Care are the Major Factors Driving the Growth of This End-User Segment
9.3 Hospitals/Critical Care Centers
9.3.1 Hospitals are Among the Largest End Users of POC Diagnostics
9.4 Home Care Settings
9.4.1 Increasing Inclination Towards Home Healthcare is Driving the Growth of This End-User Segment
9.5 Research Laboratories
9.5.1 Development of Highly Specialized POC Tests and the Increasing Adoption of POCt Devices to Support the Growth of This Segment
9.6 Other End Users
10 Point-Of-Care Diagnostics Market, By Region (Page No. – 94)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 US Dominated the North American Market in 2019
10.2.2 Canada
10.2.2.1 Rising Government Initiatives to Support the Growth of the POC Diagnostics Market in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany Accounted for the Largest Share of the European Market
10.3.2 France
10.3.2.1 Growing Public-Private Collaborations for Product Development to Drive Market Growth
10.3.3 UK
10.3.3.1 Growing Awareness of the Benefits Offered By POC Diagnostics to Support Market Growth in the UK
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.1.1 Japan Dominates the APAC POC Diagnostics Market
10.4.2 China
10.4.2.1 Rising Investments By Market Players and the Chinese Government to Drive the Growth of the POC Diagnostics Market in China
10.4.3 India
10.4.3.1 High Burden of Chronic Diseases to Support Market Growth
10.4.4 Rest of Asia Pacific
10.5 Rest of the World (RoW)
10.5.1 Latin America
10.5.1.1 Increasing Prevalence of Infectious Diseases to Drive the Adoption of POC Diagnostics
10.5.2 Middle East & Africa
10.5.2.1 Rising Prevalence of Cancer to Support Market Growth in the MEA
11 Competitive Landscape (Page No. – 133)
11.1 Introduction
11.2 Ranking of Players, 2018
11.3 Competitive Scenario
11.3.1 Product Launches, Enhancements, and Approvals
11.3.2 Agreements, Partnerships, and Collaborations
11.3.3 Acquisitions
11.4 Vendor Dive Overview
11.5 Vendor Inclusion Criteria
11.6 Vendor Dive
11.6.1 Visionary Leaders
11.6.2 Innovators
11.6.3 Dynamic Differentiators
11.6.4 Emerging Companies
12 Company Profiles (Page No. – 138)
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 Abbott Laboratories
12.2 Becton, Dickinson, and Company (BD)
12.3 Chembio Diagnostics
12.4 Danaher Corporation
12.5 Johnson & Johnson
12.6 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.)
12.7 Siemens Healthineers Group
12.8 EKF Diagnostics
12.9 Quidel
12.1 Trinity Biotech
12.11 Accubiotech
12.12 Instrumentation Laboratory (A Werfen Company)
12.13 Nova Biomedical
12.14 PTS Diagnostics (A Part of Sinocare Inc.)
12.15 Sekisui Diagnostics
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. – 183)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Author Details

List of Tables (99 Tables)
Table 1 Recent Waivers of Market Products
Table 2 Point-Of-Care Diagnostics Market, By Product, 2017–2024 (USD Million)
Table 3 Market for Glucose Monitoring Products, By Type, 2017–2024 (USD Million)
Table 4 Market for Glucose Monitoring Products, By Region, 2017–2024 (USD Million)
Table 5 Market for Cardiometabolic Monitoring Products, By Type, 2017–2024 (USD Million)
Table 6 Market for Cardiometabolic Monitoring Products, By Region, 2017–2024 (USD Million)
Table 7 Cardiac Marker Testing Products Market, By Region, 2017–2024 (USD Million)
Table 8 Blood Gas/Electrolyte Testing Products Market, By Region, 2017–2024 (USD Million)
Table 9 Hba1c Testing Products Market, By Region, 2017–2024 (USD Million)
Table 10 Market for Infectious Disease Testing Products, By Type, 2017–2024 (USD Million)
Table 11 Market for Infectious Disease Testing Products, By Region, 2017–2024 (USD Million)
Table 12 Market for Influenza Testing Products, By Region, 2017–2024 (USD Million)
Table 13 Hiv Testing Products Market, By Region, 2017–2024 (USD Million)
Table 14 Hepatitis C Testing Products Market, By Region, 2017–2024 (USD Million)
Table 15 Std Testing Products Market, By Region, 2017–2024 (USD Million)
Table 16 Healthcare-Associated Infection Testing Products Market, By Region, 2017–2024 (USD Million)
Table 17 Respiratory Infection Testing Products Market, By Region, 2017–2024 (USD Million)
Table 18 Tropical Disease Testing Products Market, By Region, 2017–2024 (USD Million)
Table 19 Other Infectious Disease Testing Products Market, By Region, 2017–2024 (USD Million)
Table 20 Market for Coagulation Monitoring Products, By Type, 2017–2024 (USD Million)
Table 21 Market for Coagulation Testing Products, By Region, 2017–2024 (USD Million)
Table 22 Pt/Inr Testing Products Market, By Region, 2017–2024 (USD Million)
Table 23 Act/Aptt Testing Products Market, By Region, 2017–2024 (USD Million)
Table 24 Market for Pregnancy & Fertility Testing Products, By Type, 2017–2024 (USD Million)
Table 25 Market for Pregnancy & Fertility Testing Products, By Region, 2017–2024 (USD Million)
Table 26 Pregnancy Testing Products Market, By Region, 2017–2024 (USD Million)
Table 27 Fertility Testing Products Market, By Region, 2017–2024 (USD Million)
Table 28 Market for Tumor/Cancer Marker Testing Products, By Region, 2017–2024 (USD Million)
Table 29 Market for Urinalysis Testing Products, By Region, 2017–2024 (USD Million)
Table 30 Market for Cholesterol Testing Products, By Region, 2017–2024 (USD Million)
Table 31 Market for Hematology Testing Products, By Region, 2017–2024 (USD Million)
Table 32 Market for Drugs-Of-Abuse Testing Products, By Region, 2017–2024 (USD Million)
Table 33 Market for Fecal Occult Testing Products, By Region, 2017–2024 (USD Million)
Table 34 Market for Other POC Products, By Region, 2017–2024 (USD Million)
Table 35 POC Diagnostics Market, By Platform, 2017–2024 (USD Million)
Table 36 Point-Of-Care Diagnostics Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 37 Prescription-Based Products Market, By Region, 2017–2024 (USD Million)
Table 38 OTC Products Market, By Region, 2017–2024 (USD Million)
Table 39 Market, By End User, 2017–2024 (USD Million)
Table 40 Market for Professional Diagnostic Centers, By Type, 2017–2024 (USD Million)
Table 41 Market for Professional Diagnostic Centers, By Region, 2017–2024 (USD Million)
Table 42 Point-Of-Care Diagnostics Market for Clinical Laboratories and Outpatient Healthcare & Ambulatory Care Settings, By Region, 2017–2024 (USD Million)
Table 43 Market for Hospitals/Critical Care Centers, By Region, 2017–2024 (USD Million)
Table 44 Market for Home Care Settings, By Region, 2017–2024 (USD Million)
Table 45 Market for Research Laboratories, By Region, 2017–2024 (USD Million)
Table 46 Market for Other End Users, By Region, 2017–2024 (USD Million)
Table 47 Market, By Region, 2017–2024 (USD Million)
Table 48 North America: Market, By Country, 2017–2024 (USD Million)
Table 49 North America: Point-Of-Care Diagnostics Market, By Product, 2017–2024 (USD Million)
Table 50 North America: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 51 North America: Point-Of-Care Diagnostics Market, By End User, 2017–2024 (USD Million)
Table 52 US: Market, By Product, 2017–2024 (USD Million)
Table 53 US: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 54 US: Market, By End User, 2017–2024 (USD Million)
Table 55 Canada: Market, By Product, 2017–2024 (USD Million)
Table 56 Canada: Point-Of-Care Diagnostics Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 57 Canada: Market, By End User, 2017–2024 (USD Million)
Table 58 Europe: Market, By Country, 2017–2024 (USD Million)
Table 59 Europe: Market, By Product, 2017–2024 (USD Million)
Table 60 Europe: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 61 Europe: Market, By End User, 2017–2024 (USD Million)
Table 62 Germany: Market, By Product, 2017–2024 (USD Million)
Table 63 Germany: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 64 Germany: Market, By End User, 2017–2024 (USD Million)
Table 65 France: Market, By Product, 2017–2024 (USD Million)
Table 66 France: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 67 France: Point-Of-Care Diagnostics Market, By End User, 2017–2024 (USD Million)
Table 68 UK: Market, By Product, 2017–2024 (USD Million)
Table 69 UK: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 70 UK: Market, By End User, 2017–2024 (USD Million)
Table 71 Roe: Market, By Product, 2017–2024 (USD Million)
Table 72 Roe: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 73 Roe: Point-Of-Care Diagnostics Market, By End User, 2017–2024 (USD Million)
Table 74 APAC: Market, By Country, 2017–2024 (USD Million)
Table 75 APAC: Market, By Product, 2017–2024 (USD Million)
Table 76 APAC: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 77 APAC: Market, By End User, 2017–2024 (USD Million)
Table 78 Japan: Market, By Product, 2017–2024 (USD Million)
Table 79 Japan: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 80 Japan: Market, By End User, 2017–2024 (USD Million)
Table 81 China: Market, By Product, 2017–2024 (USD Million)
Table 82 China: Point-Of-Care Diagnostics Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 83 China: Market, By End User, 2017–2024 (USD Million)
Table 84 India: Market, By Product, 2017–2024 (USD Million)
Table 85 India: Market, By Mode of Purchase, 2017-2024 (USD Million)
Table 86 India: Market, By End User, 2017–2024 (USD Million)
Table 87 RoAPAC: Market, By Product, 2017–2024 (USD Million)
Table 88 RoAPAC: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 89 RoAPAC: Point-Of-Care Diagnostics Market, By End User, 2017–2024 (USD Million)
Table 90 RoW: Market, By Region, 2017–2024 (USD Million)
Table 91 RoW: Market, By Product, 2017–2024 (USD Million)
Table 92 RoW: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 93 RoW: Market, By End User, 2017–2024 (USD Million)
Table 94 Latin America: Market, By Product, 2017–2024 (USD Million)
Table 95 Latin America: Market, By Mode of Purchase, 2019–2024 (USD Million)
Table 96 Latin America: Market, By End User, 2017–2024 (USD Million)
Table 97 Middle East & Africa: Market, By Product, 2017–2024 (USD Million)
Table 98 Middle East & Africa: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 99 Middle East & Africa: Market, By End User, 2017–2024 (USD Million)

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[ポイントオブケア診断の世界市場予測:グルコース、感染症(C型肝炎、インフルエンザ、呼吸器)、凝固]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆